Apollo Ingredients to Observe Trading Window Closure from April 1

Apollo Ingredients Limited has announced that its trading window for designated persons and their immediate relatives will close starting April 1, 2026. The window will remain shut for 48 hours following the public announcement of the company's audited financial results for the quarter and full year ending March 31, 2026.

Announcement Details

The company confirmed the trading window closure in a regulatory filing. The restriction begins on April 1, 2026, and will be lifted only after the audited financial statements for the period ending March 31, 2026, are officially released to the public, plus an additional 48-hour period.

Purpose of the Closure

This measure is a mandatory compliance requirement under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Its primary goal is to prevent any trading of company shares based on material, non-public information. By restricting trades during this period, the company upholds market fairness and transparency for all investors. This practice is common across listed entities to ensure adherence to insider trading norms.

Company Background and SEBI Regulations

Apollo Ingredients Limited, originally established in 1980, has undergone several name changes, including Khedapati Investments Limited and Indsoya Limited, before adopting its current name in November 2023. The company currently focuses on healthcare solutions, encompassing medicines and healthcare facility management, though it has a history of diversified business interests. SEBI's insider trading rules are a key component of corporate governance. Recent regulatory updates, such as SEBI's April 2025 circular, have expanded these closure requirements to include immediate relatives of designated individuals, reinforcing compliance across all listed companies.

Trading Restrictions

During the trading window closure, designated persons and their immediate relatives are prohibited from buying or selling Apollo Ingredients Limited's securities. This restriction covers all transactions involving the company's shares until the stipulated post-results disclosure period concludes.

Regulatory and Financial Risks

Apollo Ingredients Limited is currently involved in an appeal before the Securities Appellate Tribunal (SAT) filed in January 2026. This appeal challenges penalties imposed by BSE Limited and the freezing of promoter group demat accounts, which the company cited as alleged violations of SEBI LODR regulations. Separately, the company's paid-up capital and net worth are currently below the threshold that requires the submission of a formal corporate governance report under SEBI (LODR) Regulations, 2015.

Outlook and Next Steps

Investors and stakeholders will be monitoring the announcement of Apollo Ingredients Limited's audited financial results for the fiscal year ending March 31, 2026. The subsequent reopening of the trading window 48 hours after this announcement will also be noted, alongside any further developments regarding the company's appeal at the Securities Appellate Tribunal.